Table 2. Distribution of participants between three plasma MBL levels, participants stratified according HIV, S. haematobium and S. mansoni infection and co-infection status.
| HIV status | n | Normal MBL levels | Reduced MBL levels | Deficient MBL levels | P value |
|---|---|---|---|---|---|
| HIV positive | 197 | 113 (57%) | 41 (21%) | 43 (22%) | |
| HIV negative | 181 | 121 (67%) | 36 (20%) | 24 (13%) | 0.070 |
| S. haematobium infection | |||||
| S. haematobium positive | 205 | 131 (64%) | 38(19%) | 36 (17%) | |
| S. haematobium negative | 89 | 51 (57%) | 17(19%) | 21 (24%) | 0.446 |
| Schistosoma co-infection | |||||
| No infection (controls) | 89 | 51(57%) | 17 (195) | 21(24%) | |
| S. haematobium only | 205 | 131(64%) | 38(19%) | 36(18%0 | |
| S. mansoni only | 24 | 15(63%) | 6(25%) | 3(13%) | |
| Co-infected with both species | 37 | 23(62%) | 11(30%) | 3(8%) | 0.351 |
| HIV and S. haematobium co-infection | |||||
| HIV+/S. haematobium+ | 102 | 64(63%) | 17(17%) | 21(21%) | |
| HIV+/S. haematobium- | 44 | 23(52%) | 8(18%) | 13(30%) | |
| HIV-/S. haematobium+ | 103 | 67(65%) | 21(20%) | 15(15%) | |
| HIV-/S. haematobium- | 45 | 28(62%) | 9(20%) | 8(18%) | 0.546 |
Prevalence of MBL deficiency, plasma MBL concentration was categorised into normal (above 500μg/L), intermediate (100μg/L- 500μg/L) and deficient (below 100μg/L), analysed by the Chi Square or Fisher’s exact tests, n = 378.